TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on advancing soft-tissue reconstruction solutions, today announced the U.S. launch of larger sizes of OviTex PRS ...
Hosted on MSN3mon
FDA Approves First-Ever Tissue-Engineered Vessel for Vascular TraumaThe U.S. Food and Drug Administration (FDA) has officially approved Symvess, the first acellular tissue-engineered vessel designed to repair damaged arteries in extremities. This innovative ...
The extracellular matrix (ECM) is a dynamic bioactive acellular environment, but its critical role in driving solid tumor development, immune-cell exclusion and therapy resistance is typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback